Cidara Therapeutics to Present Ongoing Development of
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics...
Source: globenewswire.com
Cidara Cloudbreak News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cidara Cloudbreak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cidara Cloudbreak Today - Breaking & Trending Today
Cidara Therapeutics to Present Ongoing Development of Drug-Fc Conjugates (DFC) Including CD73-Targeting DFC From Its Cloudbreak® Platform at Adenosine-Pathway Targeted Cancer Immunotherapy Summit
SAN DIEGO, June 20, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious... | June 20, 2023
Source: marketscreener.com
HVIVO touts positive test results from seasonal flu drug, CD388
HVIVO PLC on Monday said that Cidara Therapeutics Inc has seen positive results from an ongoing study testing CD388, a drug designed to treat seasonal flu. hVIVO is a London-based specialist... | April 3, 2023
Source: marketscreener.com
Positive results from hVIVO study of Cidara flu candidate
Study demonstrated a reduction in viral replication in the upper respiratory tract as well as influenza infection - News - PharmaTimes
Source: pharmatimes.com
Influenza A Market to Witness Robust Expansion at a CAGR of 8.5% in the United States During the Study Period (2019-2032), Assesses DelveInsight
/PRNewswire/ -- DelveInsight's Influenza A Market Insights report includes a comprehensive understanding of current treatment practices, influenza A emerging...
Source: prnewswire.com